PUBLISHER: The Business Research Company | PRODUCT CODE: 1713523
PUBLISHER: The Business Research Company | PRODUCT CODE: 1713523
Atrial flutter is a type of abnormal heart rhythm characterized by rapid, irregular electrical signals in the atria (the heart's upper chambers), which results in a fast and often irregular heartbeat. This condition can lead to symptoms such as palpitations, shortness of breath, and fatigue, and may also increase the risk of stroke and other heart-related complications.
The primary types of atrial flutter include typical atrial flutter, atypical atrial flutter, left atrial flutter, reverse typical atrial flutter, and incisional atrial re-entry. Typical atrial flutter is a common arrhythmia where electrical signals in the right atrium of the heart circulate in a specific pattern, causing a rapid and regular heartbeat. Treatments for atrial flutter encompass antiarrhythmics, beta-blockers, anticoagulants, cardioversion, catheter ablation, surgery, and other methods. Diagnostic approaches include heart monitoring, blood tests, electrocardiography (ECG), event monitoring, and additional techniques. Routes of administration for treatments vary, including oral and intravenous options, and are utilized by various end users such as clinics, hospitals, and other healthcare settings.
The atrial flutter market research report is one of a series of new reports from The Business Research Company that provides atrial flutter market statistics, including atrial flutter industry global market size, regional shares, competitors with a atrial flutter market share, detailed atrial flutter market segments, market trends and opportunities, and any further data you may need to thrive in the atrial flutter industry. This atrial flutter market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The atrial flutter market size has grown rapidly in recent years. It will grow from $19.92 billion in 2024 to $22.99 billion in 2025 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to the increasing prevalence of cardiovascular diseases, rising awareness about atrial flutter, growing geriatric population, increasing healthcare expenditure, development of innovative anticoagulants.
The atrial flutter market size is expected to see rapid growth in the next few years. It will grow to $40.43 billion in 2029 at a compound annual growth rate (CAGR) of 15.2%. The growth in the forecast period can be attributed to emerging non-invasive treatment options, advancements in cardiac monitoring technologies, expansion of healthcare access in emerging markets, increasing investment in atrial flutter research, growing demand for personalized medicine, rising incidence of atrial flutter due to lifestyle changes, and ongoing improvements in patient management protocols. Major trends in the forecast period include advancements in wearable cardiac monitoring devices, adoption of personalized and precision medicine, growth in remote patient management solutions, expansion of market presence in emerging economies, development of new anticoagulants and antiarrhythmic drugs.
The increasing prevalence of cardiovascular diseases is anticipated to drive the growth of the atrial flutter market in the coming years. Cardiovascular diseases (CVDs) encompass a wide range of health conditions affecting the heart and blood vessels. The rise in these diseases is primarily attributed to aging populations, sedentary lifestyles, unhealthy dietary choices, rising obesity rates, and stress-related factors. As cardiovascular diseases become more prevalent, the number of individuals at risk for atrial flutter also increases, resulting in a higher demand for diagnostic and treatment options. For example, in September 2024, the British Heart Foundation, a UK-based cardiovascular research charity, reported that approximately 7.6 million people in the UK are currently affected by heart and circulatory diseases, which includes 4 million men and 3.6 million women. This figure could rise by an additional 1 million by 2030, and by 2040, it may increase by 2 million compared to current levels. Therefore, the rising incidence of cardiovascular diseases is propelling the growth of the atrial flutter market.
Leading companies in the atrial flutter market are focusing on integrating monitoring technologies, such as arrhythmia detection algorithms, to enhance diagnostic precision, improve treatment outcomes, and optimize patient management. Arrhythmia detection algorithms are advanced software tools that process data from electrocardiograms (ECGs) or wearable heart monitors to identify irregular heart rhythms and detect abnormal patterns associated with arrhythmias, including atrial flutter. For example, in May 2024, Vivalink, Inc., a U.S.-based connected health technology firm, introduced a comprehensive ambulatory cardiac monitoring solution for mobile cardiac telemetry (MCT) and Holter monitoring to improve remote patient care. This system leverages cutting-edge software to continuously analyze ECG and wearable heart monitor data, offering real-time detection of irregular heart rhythms such as atrial flutter. The solution includes a reusable ECG patch with a 14-day rechargeable battery and up to 30 days of data storage, a mobile gateway integrated with a patient app for seamless data transmission, an advanced algorithm capable of detecting more than 15 arrhythmias, and a clinician portal for detailed analysis and customized reporting.
In August 2022, Medtronic Plc, a healthcare technology company based in Ireland, acquired Affera for $925 million. This acquisition enhances Medtronic's cardiac ablation portfolio, allowing the industry leader to enter the mapping and navigation segment of electrophysiology technology for the first time. Affera is a U.S.-based healthcare technology company that specializes in treating arrhythmias.
Major companies operating in the atrial flutter market are Pfizer Inc., Johnson & Johnson, Siemens AG, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Medtronic PLC, Boehringer Ingelheim GmbH, Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Astellas Pharma Inc., Zoll Medical Corporation, St. Jude Medical Inc., Biotronik SE & Co., iRhythm Technologies Inc., AtriCure Inc., Valley Health System Inc., Adagio Medical Inc., Acutus Medical Inc
North America was the largest region in the atrial flutter market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atrial flutter market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the atrial flutter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The atrial flutter market consists of revenues earned by entities by providing services such as treatment services, diagnostic testing, and consultation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The atrial flutter market also includes sales of cardioversion devices, catheter ablation equipment, and monitoring devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Atrial Flutter Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on atrial flutter market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for atrial flutter ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The atrial flutter market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.